基本信息
浏览量:389
职业迁徙
个人简介
He has been a member of the University of California San Diego School of Medicine faculty since 1979 and is currently Professor of Surgery. He began his research career in 1965 and in 1984 he founded AntiCancer, Inc. Dr Hoffman has been a pioneer on tumor-targeting bacteria; patient-derived orthotopic xenograft (PDOX) mouse models of cancer; recombinant protein-based cancer drugs and diagnostics; as well as hair follicle-associated-pluripotent (HAP) stem cells. Dr Hoffman's research demonstrated the elevated use of methionine by all cancer types, which is called the Hoffmaneffect, analogous to the Warburg-effect of the elevated use of glucose in cancer. Dr Hoffman has published approximately 1,000 scientific papers which have been cited approximately 42,000 times with an h-index of approximately 102. In 2016, Dr Hoffman was awarded the Sun Lee Prize from the International Society for Experimental Microsurgery.
研究兴趣
论文共 1283 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
ANNALS OF SURGICAL ONCOLOGYno. 1 (2024): S47-S47
引用0浏览0引用
0
0
Cancer diagnosis & prognosisno. 3 (2024): 239-243
ANNALES D ENDOCRINOLOGIEno. 1 (2024): 89-91
IN VIVOno. 1 (2024): 253-258
ANNALS OF SURGICAL ONCOLOGYno. SUPPL 1 (2023): S53-S53
引用0浏览0引用
0
0
Journal of personalized medicineno. 5 (2023): 857-857
crossref(2023)
crossref(2023)
加载更多
作者统计
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn